**
The World Health Organization (WHO) has escalated the Ebola risk level in the Democratic Republic of Congo (DRC) from “high” to “very high” following a concerning rise in suspected cases. As of now, nearly 750 individuals are believed to be infected, with the outbreak resulting in 177 suspected fatalities. This alarming situation has prompted health authorities to intensify their response to contain the virus, particularly the rare Bundibugyo strain, which has no known vaccine and carries a mortality rate of approximately 33%.
Current Situation in the DRC
During a press briefing in Geneva, WHO Director-General Dr. Tedros Adhanom Ghebreyesus provided an overview of the escalating crisis. He reported that 82 cases have been confirmed in the DRC, with seven deaths officially recorded. The WHO has classified the risk for the wider African region as “high,” although it remains “low” on a global scale. In neighbouring Uganda, two confirmed cases of Bundibugyo and one related death have been observed, but the situation there is reportedly stable, with both cases linked to travel from the DRC.
Vaccine Development Efforts
The urgency of the outbreak has led to renewed efforts in vaccine development. Researchers at Oxford University are working on a new vaccine that could enter clinical trials within the next two to three months. This vaccine is based on the same technology used for the AstraZeneca Covid vaccine, although its efficacy is not guaranteed until thorough testing is conducted. Currently, animal trials are already underway, as confirmed by sources at the university.
In parallel, the Serum Institute of India is prepared to mass-produce the vaccine once Oxford provides the necessary medical-grade materials. Additionally, a separate experimental vaccine specifically for Bundibugyo is in the works, although it is expected to take six to nine months before any doses are ready for testing. WHO’s research and development adviser, Dr. Vasee Moorthy, has labelled this forthcoming vaccine as “the most promising,” suggesting it could offer similar protection to the already deployed Ervebo vaccine for the more common Zaire strain of Ebola.
Challenges in Containment
The response to the outbreak is hampered by significant challenges, including violence and insecurity in the region. Reports indicate that some Ebola cases have emerged from areas controlled by rebel groups, complicating efforts to manage the crisis. Trust between health authorities and local populations is critical for effective containment, yet recent incidents have strained this relationship. Following an unfortunate incident where health workers were attacked for refusing to release the body of an Ebola victim, local tensions escalated, leading to riots and property damage at Rwampara General Hospital.
Local politician Luc Malembe Malembe shared his observations of the chaotic scene, where frustrated relatives responded violently after health officials insisted on safe burial protocols to prevent further outbreaks. In such situations, the body of an Ebola victim poses a significant risk of transmission, necessitating strict adherence to health guidelines.
Community Impact and Response
Fear has permeated communities in eastern DRC as the death toll continues to climb. Residents express their anxiety over the rapid spread of the disease, with one local taxi driver stating, “Ebola has tortured us,” while another echoed sentiments of fear, noting that “people are dying very fast.” This deep-seated apprehension highlights the urgent need for effective containment strategies and community education in the face of this public health crisis.
Why it Matters
The rise in Ebola cases in the DRC serves as a sobering reminder of the persistent threat posed by infectious diseases, particularly in regions with limited healthcare resources. The situation underscores the necessity for global cooperation in vaccine development, disease monitoring, and community engagement to combat outbreaks effectively. As communities grapple with fear and uncertainty, the international health community must prioritise support and resources to mitigate the impact of this outbreak and prevent future health crises.
